JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2426
Valley National Bancorp
VLY
$7.11B
| $6M | ﹤0.01% |
535,173
+30,397
| +6% | +$352K |
2013 Q2
18 quarters
|
|
2427
Assembly Biosciences
ASMB
$468M
| $5.99M | ﹤0.01% |
11,033
-3,743
| -25% | -$1.69M |
2017 Q2
2 quarters
|
|
|
ATHN
2428
CALL
DELISTED
Athenahealth, Inc.
ATHN
| $5.99M | ﹤0.01% |
45,000
| – | – |
2016 Q4
4 quarters
|
|
|
ATHN
2429
PUT
DELISTED
Athenahealth, Inc.
ATHN
| $5.99M | ﹤0.01% |
45,000
| – | – |
2016 Q4
4 quarters
|
|
2430
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.32B
| $5.99M | ﹤0.01% |
54,470
+2,248
| +4% | +$242K |
2013 Q2
18 quarters
|
|
2431
Herc Holdings
HRI
$4.54B
| $5.97M | ﹤0.01% |
95,304
+30,109
| +46% | +$1.66M |
2013 Q2
18 quarters
|
|
2432
AstraZeneca
AZN
$244B
| $5.96M | ﹤0.01% |
85,878
+16,630
| +24% | +$1.12M |
2013 Q2
18 quarters
|
|
|
SFLY
2433
DELISTED
Shutterfly, Inc.
SFLY
| $5.94M | ﹤0.01% |
119,445
-114,291
| -49% | -$5.17M |
2015 Q4
8 quarters
|
|
2434
PUT
Puma Biotechnology
PBYI
$506M
| $5.93M | ﹤0.01% |
60,000
| – | – |
2017 Q3
1 quarter
|
|
2435
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.26B
| $5.93M | ﹤0.01% |
81,228
+2,203
| +3% | +$159K |
2013 Q4
16 quarters
|
|
2436
iShares Gold Trust
IAU
$61.9B
| $5.93M | ﹤0.01% |
236,932
-3,102,218
| -93% | -$76.1M |
2013 Q2
18 quarters
|
|
2437
AGNC Investment
AGNC
$10.8B
| $5.92M | ﹤0.01% |
293,338
-129,135
| -31% | -$2.66M |
2013 Q2
18 quarters
|
|
|
HMSY
2438
DELISTED
HMS Holdings Corp.
HMSY
| $5.92M | ﹤0.01% |
349,319
-397,698
| -53% | -$6.96M |
2014 Q4
12 quarters
|
|
2439
abrdn Physical Gold Shares ETF
SGOL
$6.98B
| $5.92M | ﹤0.01% |
468,960
| – | – |
2013 Q2
18 quarters
|
|
2440
Ligand Pharmaceuticals
LGND
$6.05B
| $5.91M | ﹤0.01% |
69,157
+44,028
| +175% | +$3.82M |
2015 Q4
8 quarters
|
|
2441
United Bankshares
UBSI
$6.4B
| $5.89M | ﹤0.01% |
169,559
+163,435
| +2,669% | +$5.89M |
2014 Q4
12 quarters
|
|
2442
PUT
PayPal
PYPL
$45.6B
| $5.89M | ﹤0.01% |
80,000
-39,600
| -33% | -$2.86M |
2015 Q3
9 quarters
|
|
|
EMWP
2443
DELISTED
Eros Media World PLC
EMWP
| $5.89M | ﹤0.01% |
30,499
-876
| -3% | -$216K |
2016 Q4
4 quarters
|
|
2444
CALL
Century Aluminum
CENX
$3.61B
| $5.86M | ﹤0.01% |
+298,500
| New | +$4.57M |
2017 Q4
0 quarters
|
|
|
FIT
2445
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $5.86M | ﹤0.01% |
1,026,015
-599,649
| -37% | -$3.82M |
2015 Q2
10 quarters
|
|
|
IBKC
2446
PUT
DELISTED
IBERIABANK Corp
IBKC
| $5.86M | ﹤0.01% |
+75,600
| New | +$5.81M |
2017 Q4
0 quarters
|
|
2447
Liberty Global Class A
LBTYA
$3.08B
| $5.86M | ﹤0.01% |
163,383
+27,907
| +21% | +$887K |
2013 Q2
18 quarters
|
|
|
FBR
2448
DELISTED
Fibria Celulose Sa
FBR
| $5.85M | ﹤0.01% |
398,052
-258,927
| -39% | -$3.94M |
2015 Q3
9 quarters
|
|
2449
CALL
State Street
STT
$48.4B
| $5.85M | ﹤0.01% |
+59,900
| New | +$5.73M |
2017 Q4
0 quarters
|
|
2450
CALL
Procter & Gamble
PG
$335B
| $5.84M | ﹤0.01% |
63,600
+31,700
| +99% | +$2.85M |
2014 Q3
13 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.